Vir Biotechnology, Inc. (CIK: 0001706431) EDGAR, Information, Filings... CompaniesBIO.Com

Vir Biotechnology, Inc.

Mailing address
499 ILLINOIS STREET, SUITE 500, SAN FRANCISCO, Delaware, 94158
Phone
415-906-4324
State location
California
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

Vir Biotechnology, Inc. (CIK: 0001706431) is an American company incorporated in the state of California. Head office is located at 499 ILLINOIS STREET, SUITE 500, SAN FRANCISCO, California, 94158. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). Vir Biotechnology, Inc. is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
De Backer Marianne	0001797819	Apr-03-2023	officer: Chief Executive Officer
Lee Sung	0001793200	Mar-27-2023	officer: Chief Financial Officer
Friedl-Naderer Johanna	0001915598	Mar-02-2022	officer: Chief Business Officer, Global
CRANDELL KEITH	0001219039	Mar-30-2021	10 percent owner
NELSEN ROBERT	0001219042	Mar-30-2021	director, 10 percent owner
BYBEE CLINTON	0001219043	Mar-30-2021	10 percent owner
ARCH Venture Fund IX, L.P.	0001666306	Mar-30-2021	10 percent owner
ARCH Venture Fund IX Overage, L.P.	0001666307	Mar-30-2021	10 percent owner
ARCH Venture Partners IX Overage, L.P.	0001723172	Mar-30-2021	10 percent owner
ARCH Venture Partners IX, L.P.	0001723173	Mar-30-2021	10 percent owner
ARCH Venture Partners IX, LLC	0001723174	Mar-30-2021	10 percent owner
HANLY ANN M.	0001854528	Mar-29-2021	officer: Chief Technology Officer
Hatfield Jeffrey S.	0001609879	Dec-09-2020	director
Napolitano Janet	0001821008	Aug-28-2020	director
Rice Steven J.	0001820108	Jul-30-2020	officer: Chief Administrative Officer
Sigal Charles Elliott	0001661908	Jul-10-2020	director
V-Sciences Investments Pte Ltd	0001379350	Oct-16-2019	10 percent owner
Temasek Holdings (Private) Ltd	0001021944	Oct-10-2019	10 percent owner
SATO VICKI L	0001197020	Oct-10-2019	director
SCANGOS GEORGE A	0001202102	Oct-10-2019	director, officer: President and CEO
MORE ROBERT J	0001207792	Oct-10-2019	director
SHARP PHILLIP A	0001226295	Oct-10-2019	director
PEREZ ROBERT J	0001263230	Oct-10-2019	director
Abu Dhabi Investment Authority	0001362558	Oct-10-2019	10 percent owner
Fullerton Management Pte Ltd	0001379348	Oct-10-2019	10 percent owner
Temasek Life Sciences Private Ltd	0001379349	Oct-10-2019	10 percent owner
Kamarck Michael E.	0001450730	Oct-10-2019	officer: Chief Technology Officer
Nishar Dipchand	0001519500	Oct-10-2019	director
Ramasastry Saira	0001547959	Oct-10-2019	director
Burow Kristina	0001569248	Oct-10-2019	director
Alaska Permanent Fund Corp	0001582681	Oct-10-2019	10 percent owner
Bill & Melinda Gates Foundation	0001663801	Oct-10-2019	10 percent owner
TLS Beta Pte. Ltd.	0001673754	Oct-10-2019	10 percent owner
SB INVESTMENT ADVISERS (UK) LTD	0001731509	Oct-10-2019	10 percent owner
SOFTBANK VISION FUND (AIV M1) L.P.	0001755143	Oct-10-2019	10 percent owner
SVF Endurance (Cayman) Ltd	0001782338	Oct-10-2019	10 percent owner
Frueh Klaus	0001786308	Oct-10-2019	director
Horn Howard	0001786335	Oct-10-2019	officer: CFO
Parrish Jay	0001786372	Oct-10-2019	officer: Chief Business Officer
Virgin Herbert	0001786378	Oct-10-2019	officer: EVP, Research & CSO
Pang Phillip	0001787370	Oct-10-2019	officer: Chief Medical Officer
Q-Ventures Program II (Co-Invest Holdings) Ltd.	0001790363	Oct-10-2019	10 percent owner
Platinum International Investment Holding RSC Ltd	0001790748	Oct-10-2019	10 percent owner
Platinum Falcon B 2018 RSC Ltd	0001790749	Oct-10-2019	10 percent owner
Quinn Christopher	0001791072	Oct-10-2019	10 percent owner
Angella Frank G.	0001791076	Oct-10-2019	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Vir Biotechnology, Inc.

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-040035 ( Act) Size: 0 KB	Sep-10-2024
8-K	Document	Current report filing Acc-no: 0001628280-24-039948 (34 Act) Size: KB	Sep-10-2024	001-39083 241288777
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001950047-24-006897 (33 Act) Size: 0 KB	Sep-09-2024	001-39083 241287589
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0001628280-24-034195 (34 Act) Size: KB	Aug-01-2024	001-39083 241167439
8-K	Document	Current report filing Acc-no: 0001628280-24-034143 (34 Act) Size: KB	Aug-01-2024	001-39083 241166745
8-K	Document	Current report filing Acc-no: 0001193125-24-191500 (34 Act) Size: KB	Aug-01-2024	001-39083 241166681
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0000950170-24-083951 ( Act) Size: 0 KB	Jul-16-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001972362-24-000951 (33 Act) Size: 0 KB	Jul-10-2024	001-39083 241109829
8-K	Document	Current report filing Acc-no: 0001193125-24-168554 (34 Act) Size: KB	Jun-26-2024	001-39083 241070679
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-027797 ( Act) Size: 0 KB	Jun-12-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-027760 ( Act) Size: 0 KB	Jun-12-2024
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001972362-24-000891 (33 Act) Size: 0 KB	Jun-11-2024	001-39083 241036548
144	Document	Filing for proposed sale of securities under Rule 144 Acc-no: 0001972362-24-000867 (33 Act) Size: 0 KB	Jun-07-2024	001-39083 241030504
8-K	Document	Current report filing Acc-no: 0001193125-24-154636 (34 Act) Size: KB	Jun-05-2024	001-39083 241020632
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-026221 ( Act) Size: 0 KB	Jun-03-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-026219 ( Act) Size: 0 KB	Jun-03-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-026217 ( Act) Size: 0 KB	Jun-03-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-026215 ( Act) Size: 0 KB	Jun-03-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-026213 ( Act) Size: 0 KB	Jun-03-2024
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001628280-24-026211 ( Act) Size: 0 KB	Jun-03-2024

Recent 20 filings. View all Vir Biotechnology, Inc. filings

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Vir Biotechnology, Inc. overview
Vir Biotechnology, Inc. job
Vir Biotechnology, Inc. stock
Vir Biotechnology, Inc. ownership
Vir Biotechnology, Inc. CEO
Vir Biotechnology, Inc. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.